Assignee
ARBUTUS BIOPHARMA CORP
CA52 patents
Top patents by PatentIndex Score
US9682139B2Jun 20, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP46 citations98
US11141378B2Oct 12, 2021
Lipid formulations for nucleic acid delivery
ARBUTUS BIOPHARMA CORP42 citations97
US10561732B2Feb 18, 2020
Trialkyl cationic lipids and methods of use thereof
ARBUTUS BIOPHARMA CORP13 citations94
US9814777B2Nov 14, 2017
Targeting lipids
ARBUTUS BIOPHARMA CORP8 citations93
US10653780B2May 19, 2020
Amino lipids and methods for the delivery of nucleic acids
ARBUTUS BIOPHARMA CORP28 citations92
US10117941B2Nov 6, 2018
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP12 citations92
US9764036B2Sep 19, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP19 citations92
US12016929B2Jun 25, 2024
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP5 citations86
US11786598B2Oct 17, 2023
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP7 citations86
US11446383B2Sep 20, 2022
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP6 citations86
US11718852B2Aug 8, 2023
Non-liposomal systems for nucleic acid delivery
ARBUTUS BIOPHARMA CORP5 citations85
US11077197B2Aug 3, 2021
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP3 citations84
US10821186B2Nov 3, 2020
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP4 citations84
US10456473B2Oct 29, 2019
Lipid compositions
ARBUTUS BIOPHARMA CORP6 citations84
US10053689B2Aug 21, 2018
Methods for increasing efficacy of lipid formulated siRNA
ARBUTUS BIOPHARMA CORP7 citations84
US9895448B2Feb 20, 2018
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
ARBUTUS BIOPHARMA CORP5 citations84
US9707292B2Jul 18, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP5 citations84
US9636301B2May 2, 2017
In vitro release assay for liposome encapsulated vincristine
ARBUTUS BIOPHARMA CORP29 citations84
US11318098B2May 3, 2022
Liposomal apparatus and manufacturing methods
ARBUTUS BIOPHARMA CORP3 citations83
US11298320B2Apr 12, 2022
Liposomal apparatus and manufacturing methods
ARBUTUS BIOPHARMA CORP3 citations83
US11427823B2Aug 30, 2022
Targeted compositions
ARBUTUS BIOPHARMA CORP5 citations82
US11191849B2Dec 7, 2021
Compositions and methods for delivering messenger RNA
ARBUTUS BIOPHARMA CORP10 citations79
US10415037B2Sep 17, 2019
Compositions and methods for silencing hepatitis B virus gene expression
ARBUTUS BIOPHARMA CORP7 citations76
US12042541B2Jul 23, 2024
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations73
US11420931B2Aug 23, 2022
Lipid containing formulations
ARBUTUS BIOPHARMA CORP2 citations73
US11395854B2Jul 26, 2022
Trialkyl cationic lipids and methods of use thereof
ARBUTUS BIOPHARMA CORP1 citations73
US10953095B2Mar 23, 2021
Lipid compositions
ARBUTUS BIOPHARMA CORP1 citations73
US10358447B2Jul 23, 2019
Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same
ARBUTUS BIOPHARMA CORP3 citations73
US9694077B2Jul 4, 2017
Lipid compositions
ARBUTUS BIOPHARMA CORP3 citations73
US12129467B2Oct 29, 2024
Non-liposomal systems for nucleic acid delivery
ARBUTUS BIOPHARMA CORP2 citations72
US10626393B2Apr 21, 2020
Delivering CRISPR therapeutics with lipid nanoparticles
ARBUTUS BIOPHARMA CORP6 citations65
US12023383B2Jul 2, 2024
Lipid compositions
ARBUTUS BIOPHARMA CORP0 citations63
US12453776B2Oct 28, 2025
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations62
US10550084B2Feb 4, 2020
Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same
ARBUTUS BIOPHARMA CORP1 citations62
US12350383B2Jul 8, 2025
Cationic lipids containing silicon
ARBUTUS BIOPHARMA CORP0 citations61
US12043833B2Jul 23, 2024
Targeted compositions
ARBUTUS BIOPHARMA CORP1 citations60
US11712476B2Aug 1, 2023
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations59
US12083118B2Sep 10, 2024
Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same
ARBUTUS BIOPHARMA CORP2 citations58
US11505551B2Nov 22, 2022
Methods for preparing substituted pyridinone-containing tricyclic compounds
ARBUTUS BIOPHARMA CORP0 citations58
US11130740B2Sep 28, 2021
Substituted 2,3-dihydro-1H-indene analogs and methods using same
ARBUTUS BIOPHARMA CORP0 citations57
US11013726B2May 25, 2021
Substituted pyridinone-containing trycyclic compounds, and methods using same
ARBUTUS BIOPHARMA CORP0 citations57
US11566002B2Jan 31, 2023
Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same
ARBUTUS BIOPHARMA CORP1 citations56
US12251470B2Mar 18, 2025
Lipid nanoparticle formulations
ARBUTUS BIOPHARMA CORP0 citations55
US11896672B2Feb 13, 2024
Targeted nucleic acid conjugate compositions
ARBUTUS BIOPHARMA CORP0 citations52
US10835612B2Nov 17, 2020
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations52
US11904052B2Feb 20, 2024
Methods for ameliorating infusion reactions
ARBUTUS BIOPHARMA CORP0 citations51
US11351118B2Jun 7, 2022
Methods for ameliorating infusion reactions
ARBUTUS BIOPHARMA CORP1 citations51
US12357705B2Jul 15, 2025
Negatively charged peg-lipid conjugates
ARBUTUS BIOPHARMA CORP0 citations50
US11702427B2Jul 18, 2023
Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same
ARBUTUS BIOPHARMA CORP0 citations49
US11098010B2Aug 24, 2021
Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same
ARBUTUS BIOPHARMA CORP0 citations46
Showing the top 50 of 52 patents by PatentIndex Score.